-
Innovation Ranking
Innovation Ranking – Graybug Vision Inc
CalciMedica Inc (CalciMedica), formerly Graybug Vision Inc, is a clinical-stage pharmaceutical company that develops next-generation products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. Its pipeline portfolio comprise GB-102, GB-601, GB-701, GB-501 and GB-401.The company’s lead candidate includes GB-102, a clinical-stage depot formulation of sunitinib malatcontains, which is a single small molecule compound that blocks multiple pathogenic angiogenesis pathways included in choroidal neovascularization that causes neovascular or wet age-related macular degeneration. It develops products for...
-
Product Insights
Likelihood of Approval Analysis for Vision Disorders
Overview How likely is it that the drugs in Vision Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vision Disorders Overview Vision disorders are characterized by poor or unclear vision...
-
Sector Analysis
Automotive Vision Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Vision Systems Market Report Overview The automotive vision systems market size was estimated at 709.3 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. Increased consumer awareness regarding road safety and a desire for advanced features are driving the growth of vision system technologies. The Asia-Pacific region had a significant share in the automotive vision systems market. Automotive Vision Systems Market Outlook 2023-2028 (Million Units) Buy the Full Report for Additional...
-
Sector Analysis
NewDecoding Apple’s YouTube Advertising Strategy in Q1 2024
This comprehensive report examines Apple Inc.'s advertising strategy on YouTube during January 1 to March 31, 2024. It dissects targeted demographics, core values, and conveyed benefits, emphasizing values like innovation and reliability. Utilizing metrics such as viewership and consumer engagement, the report evaluates the effectiveness of these strategies. It delves into how Apple Inc. communicates its brand values and aims to resonate with its audience. Through thematic approaches, it seeks to establish emotional connections with consumers, providing valuable insights for...
-
Product Insights
NewOptical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Optical Coherence Tomography Pipeline Market Report Overview Optical coherence tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The optical coherence tomography pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       United...
-
Product Insights
Likelihood of Approval Analysis for Retinal Degeneration
Overview How likely is it that the drugs in Retinal Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Degeneration Overview Retinal degeneration refers to a group of diseases that...
-
Sector Analysis
Retinitis Pigmentosa (RP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Retinitis Pigmentosa (RP) Marketed and Pipeline Drugs Report Overview Retinitis pigmentosa (RP) is a cluster of rare eye conditions. One of these conditions causes degeneration of the retina, the light-sensitive layer at the back of the eye. This degeneration results in a progressive loss of vision. Retinitis pigmentosa is an inherited genetic disorder. Most people have progressive vision loss over time, with symptoms usually starting in childhood. While there isn't a cure at this time, people can maximize their residual...
-
Product Insights
Likelihood of Approval Analysis for Diabetic Retinopathy
Overview How likely is it that the drugs in Diabetic Retinopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Retinopathy Overview Diabetic retinopathy is a complication of diabetes that affects...
-
Product Insights
Likelihood of Approval Analysis for Age Related Macular Degeneration
Overview How likely is it that the drugs in Age Related Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Age Related Macular Degeneration Overview Macular degeneration, also known as...